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To determine which aspects of breast cancer genetic counselling are important to Ashkenazi Jewish women, a discrete choice
experiment was conducted. Participants consisted of 339 Australian Ashkenazi Jewish women who provided a blood sample for
research used to test for Ashkenazi Jewish ancestral mutations in the genes BRCA1 and BRCA2, and were offered their genetic test
result through a cancer genetics service. Main outcome measures were women’s preferences for, and trade-offs between, the genetic
counselling aspects of providing cancer, gene, and risk information (information); giving advice about cancer surveillance (surveillance);
preparing for genetic testing (preparation); and, assistance with decision-making (direction). Respondents most valued information,
about twice as much as advice about surveillance, four times as much as preparation for testing, and nine times as much as assistance
with decision-making, which was least valued. Women’s preferences were consistent with the major goals of genetic counselling,
which include providing information and surveillance advice, and avoiding direction by facilitating autonomous decision-making. There
were differences between the women in which aspects they most favoured, suggesting that counselling that elicits and responds to
clients’ preferences is more likely to meet clients’ needs.
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Shortly after the cloning of the breast cancer susceptibility genes
BRCA1 and BRCA2, three specific mutations in BRCA1 and BRCA2
were found to be 20 times more common in individuals of
Ashkenazi Jewish descent than in the general population (Struewing
et al, 1997). These ancestral mutations are thought to account for
20% of all breast cancer in Ashkenazi Jewish women (Satagopan
et al, 2001). Carriers of a mutation in either of these genes are at
40–60% lifetime risk of developing breast cancer and 20–40%
lifetime risk of developing ovarian cancer (Robson et al, 1997;
Fodor et al, 1998; Hartge et al, 1999; Satagopan et al, 2001).
In the past decade, there has been a rapid increase in the
demand for, and availability of, breast cancer genetics services
(Thompson et al, 1995). These services aim to provide women with
an estimate of their risk of developing breast and ovarian cancer
based on their family history, and in some cases, genetic testing for
mutations in BRCA1 and BRCA2 is offered. These services may
further aim to improve psycho-social outcomes for clients by
inclusion of other specialities and techniques, including, facilitat-
ing autonomous decision-making about genetic testing and risk-
reduction options, preparing clients for the possible outcomes
of genetic testing, and offering family or group therapy sessions.
In recent years, many services have established multidisciplinary
teams including surgeons, oncologists, and gynaecologists so that
breast and ovarian cancer surveillance advice can be provided.
Outcomes of genetic counselling may relate to process issues,o r
may relate to desired client outcomes. Process issues, such as
satisfaction with consultation waiting time, location, duration of
counselling sessions, and type of service provider, have been
examined in a number of studies (Shiloh et al, 1990; Bernhardt
et al, 2000; Brain et al, 2000; Metcalfe et al, 2000; Wilson et al,
2000; Holloway et al, 2004; Pieterse et al, 2005a,b). Client
outcomes are more difficult to measure than process issues, but
are more salient for evaluating and informing service delivery
(Clarke et al, 1996; Cappelli et al, 2001). Desired client outcomes,
such as reduced anxiety, improved genetic knowledge, and risk
perception, have received some attention in the literature
(Bernhardt et al, 2000, Metcalfe et al, 2000; Pieterse et al, 2005a,b).
Desired client outcomes may be influenced by several factors
including clients’ needs, their expectations and their preferences
before counselling, and also the fulfilment, or perceived fulfilment,
of these factors after counselling. Studies of expectations before
genetic counselling have shown that clients often do not know the
procedure or structure of the counselling appointment, sometimes
resulting in the client feeling that he or she was inadequately
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sprepared (Hallowell et al, 1997; Stadler et al, 1998; Berkenstadt
et al, 1999; Bernhardt et al, 2000; Holloway et al 2004). Studies of
preferences measured before genetic counselling have further
shown that clients have high preference for information, although
it is difficult to interpret findings regarding preferences for aspects
other than information given clients’ lack of knowledge about the
counselling process before attendance (Cohn et al, 2003; Tiller
et al, 2005).
In this study, we elicited preferences for genetic service delivery
in Jewish women who had previously participated in a BRCA1 and
BRCA2 genetic testing programme, and so had knowledge of the
procedures of genetic counselling. The aim of this study was to
measure strength of preference for the different aspects of genetic
counselling outcomes in these women. Discrete choice experiments
are a theoretically valid technique developed by psychologists and
economists for eliciting preferences, and are particularly well
suited to eliciting preferences for the wide range of health and
nonhealth benefits potentially derived from using health services
(Ryan, 1999, 2004; Ryan and Farrar, 2000; Sculpher et al, 2004). We
used a discrete choice experiment to provide robust information
about what aspects clients want most from genetic counselling, the
relative value they place on different counselling aspects, and how
much value they place on the different aspects.
MATERIALS AND METHODS
Study sample
Eligible women were participants in the Australian Jewish Breast
Cancer Study (AJBCS) (Apicella et al, 2003) who had previously
received their genetic test results and enrolled in the study at least
6 months earlier. Participants recruited in the previous 6 months
were excluded because many had not yet attended a genetic clinic
for genetic counselling and result disclosure appointments. At
recruitment, participants were administered a structured ques-
tionnaire developed by the Breast Cancer Family Registry,
provided a blood sample that was tested for the Jewish ancestral
mutations in BRCA1 and BRCA2, and received genetic information
(John et al, 2004). Most women subsequently received their genetic
test result through one of six state-funded cancer genetics services,
as described previously (Apicella et al, 2006).
Discrete choice experiment
A follow-up questionnaire was mailed to all 339 participants. The
questionnaire included a discrete choice experiment for prefer-
ences of attributes (aspects) of genetic counselling. These
attributes were identified through reviews of the peer reviewed
and policy/practice literature on genetic counselling, consultation
with clinical geneticists, genetic counsellors, heads of genetic
services, psychologists, and interviews with participants (Apicella
et al, 2006). The four identified attributes included in the discrete
choice experiment were: providing and explaining cancer, gene
and risk information (Information); explaining options and giving
advice about appropriate surveillance for breast and ovarian
cancer (Surveillance); preparing for the outcomes of genetic testing
(Preparation); and, receiving help in deciding whether or not to
have a genetic test (Direction).
Descriptions were developed for each of the counselling
attributes to help participants understand the nature of each that
they were being asked to consider (see Figure 1). The critical task
in describing attributes was to ensure they captured the desired
client outcomes relevant to women attending the participating
Figure 1 Attribute-ranking question used in the follow-up questionnaire.
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sgenetics services. To this end, clinical geneticists and counsellors
who counselled the participants at these services played a central
role in developing the descriptions. The four items and their
descriptions were developed to capture information, emotional
and psychosocial support, surveillance advice, and direction
outcomes relevant to their practices.
Respondents were asked to rank their preferences for each of the
four attributes at a genetic counselling appointment, where rank
one is their most preferred and rank four is their least preferred.
Strength of preference for each was then measured using a discrete
choice experiment (see Figure 2).
Discrete choice experiments measure preferences by analysing
individuals’ responses to questions about choices they would make
in hypothetical, yet realistic, situations. Respondents are asked to
choose their preferred option (in this case different counselling
appointments described by a unique combination of different
levels for each of the counselling attributes) from a series of
pairwise choices. A probabilistic discrete choice model was used to
analyse the data.
Each discrete choice question asked respondents to choose
between two hypothetical genetic counselling appointments
described in terms of different levels of the four counselling
attributes. Scenarios were paired randomly. Three attribute levels
were used in the experimental design according to the amount
of discussion – none, some, or a lot – devoted to each attribute
during a counselling appointment. Respondents were therefore
asked which of the two hypothetical genetic counselling appoint-
ments they would prefer, where alternative appointments were
described in terms of different levels for the four attributes (see
Figure 2). The SPEED computer package was used to select the
optimal subset of scenarios, making the number of discrete choice
questions manageable (Bradley, 1991).
An internal consistency test was included with the discrete
choice experiment. This involved presenting a choice of counsel-
ling appointments with attribute levels such that all respondents
should choose the same appointment. Only responses that showed
internal consistency were included in the subset for analysis.
Statistical analysis
A random effects probit regression model was used to analyse the
discrete choice data (Ryan and Farrar, 2000) using Stata v8.2.
RESULTS
Respondents
Of the 339 AJBCS participants who were sent the follow-up
questionnaire (average 44 months after enrolment in the study),
256 (76%) were completed and returned. Table 1 shows the mean
(s.d.) age of respondents was 52.6 years (12.0). The mean number
of children was 2.0 (1.2). The mean genetic knowledge score was
6.8 (1.9). The mean State Trait Anxiety Inventory score was 38.8
(10.4). Thirty participants were found to be mutation carriers.
Older women had more children (Po0.01) and were more likely to
have had cancer (Po0.01). Younger women were more likely to
Figure 2 Example of a discrete choice experiment question used in the follow-up questionnaire.
Table 1 Descriptive characteristics of respondents





Mean (s.d.) 52.56 (11.96)
Number of children N¼205
0 33 (16)
1 21 (10)
2 or 3 138 (67)
4 or more 13 (6)







Family history (first- and second-degree relative) N¼207
1 case breast cancer 74 (36)
2 cases breast cancer 51 (25)
3 or more cases breast cancer 52 (25)
Carrier of ancestral mutation 30 (14)
Genetic test result received N¼210
Yes 187 (89)
No 23 (11)
Genetic knowledge (max. 9) N¼209
1–3 (poor) 19 (9)
4–6 (fair) 44 (21)
7–9 (good) 146 (70)





Mean (s.d.) 38.84 (10.43)
Recent death of a relative N¼202
Yes 44 (22)
No 158 (78)
Recent cancer of a relative N¼202
Yes 42 (21)
No 160 (79)
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shave a university degree (Po0.01), and had better genetic
knowledge (Po0.01). Recent death in the family was associated
with a strong family history of cancer (three or more cases of
breast or ovarian cancer in first- and second-degree relatives)
(Po0.01) and recent cancer diagnosis in the family (Po0.01).
Simple attribute ranking
Simple attribute-ranking preferences are presented elsewhere
(Apicella et al, 2006). More than 60% of respondents ranked
information as the most important attribute. Approximately 20
and 15% of respondents ranked surveillance and preparation as
the most important attribute, respectively. Only 5% ranked
direction as most important. More than 50% of respondents
ranked direction as the least important attribute. Approximately
20% ranked surveillance, 25% preparation, and 5% information as
least important, respectively. Preferences were not significantly
different between the mutation carriers and noncarriers (Apicella
et al, 2006). Rankings for the most important attribute for
mutation carriers and noncarriers, respectively, were 67 and 61%
for information; 13 and 20% for surveillance; 17 and 14% for
preparation; 3 and 5% for direction.
Discrete choice experiment
Of the 209 women who completed all five discrete choice
questions, 193 (92%) passed the consistency test. The random
effects probit model was fitted using responses from these 193
respondents (Table 2). All main effects, the bj coefficients, were
positive and significant at the 1% level, except direction, which was
significant at the 5% level, showing that increased amounts of
discussion for each attribute were associated with increased utility
(attributes are monotonically increasing in levels).
The most important attribute was information, followed by
surveillance, and then preparation (Table 2). The least important
attribute was direction. The main effects, statistically significant
for all four attributes, showed that increasing the level (from none
to some or from some to a lot) of discussion of information, utility
increased by 0.997. Increasing the level of discussion of
surveillance, preparation, and direction increased utility by
0.463, 0.267, and 0.114, respectively.
Table 3 shows the relative value, or importance, of the different
attributes, given by the ratios (binfo/bdirn) of the main effects. In
this study, women would give up 8.75 units of discussion of
direction to get an extra unit of discussion of information. That is,
information was found to be almost nine times as important as
direction. Alternatively, it could be viewed that women would only
give up 0.11 units of discussion of information to get an extra unit
of discussion of direction. These data also show that discussion of
information was more than three times as important as discussion
of preparation, and more than twice as important as discussion of
surveillance. Similarly, discussion of surveillance was four times
more important than discussion of direction, and discussion of
preparation was more than twice as important as discussion of
direction.
The effects of respondents’ personal characteristics and
experiences on the relative value of attributes were examined to
determine whether preferences vary systematically between
respondents. This was performed by modelling potential interac-
tions between characteristics and preferences in the regression
model (segmentation analysis). Personal characteristics included
demography, education, parity, psychological well-being, per-
sonal and family cancer history, mutation carrier status, and
genetic knowledge. No statistically significant relationships were
identified.
DISCUSSION
Women had highest preference for information, valuing it almost
nine times more than direction in decision-making about genetic
testing. This is consistent with the major aims of cancer genetic
services, which include providing cancer, genetic and risk
information, and facilitating autonomous decision-making. Women
also had high preference for discussion of breast and ovarian
cancer surveillance options, valuing it twice as much as prepara-
tion for possible outcomes of genetic testing, and four times as
much as direction in decision-making about genetic testing. This
provides evidence that the shift towards a multidisciplinary
team, which includes oncologists and surgeons able to provide
surveillance advice is consistent with women’s preferences for
genetic counselling. The discrete choice experiment results are
entirely consistent with results from attribute-ranking questions
presented in Apicella et al (2006).
Although many women preferred information most, and
assistance with decision-making least, there were differences
between women in which aspects they most favoured. In
particular, we found that some women valued preparation highly,
whereas others placed least value on this aspect of genetic
counselling. Since analysing these data, we have become aware of
another study which has similarly found that in general, clients
preferred information most and emotional support least, although
a subset had high preference for emotional support (Pieterse et al,
2005b).
The results from this study suggest that a uniform and
structured genetic counselling appointment may not be the best
method of service delivery, as preferences vary between
clients, and fulfilment of clients’ preferences are important for
achieving desired client outcomes. This has also been demon-
strated recently by Pieterse et al (2005b), who showed that desired
client outcomes such as increased perceived personal control and
reduced anxiety are significantly positively associated with clients’
perceptions that their preferences for service delivery were met.
That is, studies that help to identify client preferences both in
general and in specific subgroups may assist in improving the
delivery of genetic services.
Participants of this study have undergone genetic counselling,
and most have received their genetic test result, meaning that they
are well placed to identify attributes of genetic services that are
important to users of those services (Genetic Interest Group, 1998;
Royal College of Physicians, 1998). The importance of eliciting
Table 2 Random effects probit model results
Main effect
a (bj) s.e. 95% Cl P4|z|
Information 0.997 0.113 0.776–1.218 0.000
Surveillance 0.463 0.036 0.393–0.533 0.000
Preparation 0.267 0.045 0.182–0.353 0.000
Direction 0.114 0.047 0.023–0.206 0.014
CI¼confidence interval. Individuals¼193; observations¼965. Log-like-




approach to estimating the main effects model is to use dummy variables for
categorical attribute levels in the independent variable set. However, this approach
becomes problematic owing to colinearity in the set of dummy variables.
Table 3 Relative value of attributes: ratios of main effects
Main effect (bj) bj/binfo bj/bsurv bj/bprep bj/bdirn
Information 0.997 1.00 2.15 3.73 8.75
Surveillance 0.463 0.46 1.00 1.73 4.06
Preparation 0.267 0.27 0.58 1.00 2.34
Direction 0.114 0.11 0.25 0.43 1.00
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spreferences from respondents with first-hand experience of
genetics and genetics services in understanding the attributes of
genetics services has been recognised elsewhere (Wilson et al,
2000).
Given a priori expectations, the discrete choice experiment
results are plausible, and provide further evidence that the
technique can be successfully applied in health care. Discrete
choice experiments have been shown to provide internally valid
and consistent responses (Viney et al, 2002; Ryan and Gerard,
2003; Ryan et al, 2003). However, this may depend on study
context (Ryan and Gerard, 2002), and there is some evidence that
some respondents may not trade-off attributes, but adopt simpler
decision heuristics (Scott, 2002; Lloyd, 2003). Although the choices
presented to respondents are hypothetical, this allows researchers
to have complete control over experimental design and ensures
statistical robustness (Ubach et al, 2003). An important question
with any stated preference technique is that of external validity:
would respondents make the same choices in reality? Surveying
respondents with first-hand experience genetics services, and
evidence from other areas such as the valuation of environmental
goods and services means that we can be optimistic (Wilson et al,
2000; Ryan, 2004). Clearly, future research on these topics is
warranted.
It remains to be seen whether results from this study are
generalisable to other populations and to other types of genetic
testing, owing to differences in the characteristics of participants
of this study and of other populations seeking cancer genetic
counselling. Such differences include; specific testing with a more
definitive outcome was conducted in the Ashkenazi Jewish
population, whereas there is often no definitive outcome from
BRCA1 and BRCA2 testing in the general population; the extent
of family cancer history of participants may differ from other
populations undergoing BRCA1 and BRCA2 testing; and, other
cultural groups may value counselling outcomes differently.
Nonetheless, a study of preferences for cancer genetic counselling
in a Dutch population found that clients had similar preferences to
those identified in this study of Australian Jewish women (Pieterse
et al, 2005b), suggesting that findings from this study may apply to
other populations.
The discrete choice experiment technique could be further used
to elicit client preferences for a range of other health and
nonhealth objectives relating to genetics services. In particular,
access to genetics services may be improved if genetics testing
becomes available through general practitioners on a widespread
basis. However, this might be associated with a more limited
service for clients, as most general practitioners will not have the
time or level of genetics training as found in dedicated genetic
clinics. A discrete choice experiment could be used to measure the
value that clients place on improving access to genetics services
relative to the amount of information and other aspects of genetic
counselling that they would receive from their local family doctor
compared to a genetic clinic.
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